Ontology highlight
ABSTRACT: Objective
Proton pump inhibitors are frequently administered on clinical symptoms in neonates but benefit remains controversial. Clinical trials validating omeprazole dosage in neonates are limited. The objective of this trial was to determine the minimum effective dose (MED) of omeprazole to treat pathological acid reflux in neonates using reflux index as surrogate marker.Design
Double blind dose-finding trial with continual reassessment method of individual dose administration using a Bayesian approach, aiming to select drug dose as close as possible to the predefined target level of efficacy (with a credibility interval of 95%).Setting
Neonatal Intensive Care unit of the Robert Debré University Hospital in Paris, France.Patients
Neonates with a postmenstr
SUBMITTER: Kaguelidou F
PROVIDER: S-EPMC5176365 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature